Your browser doesn't support javascript.
Early Emergence Phase of SARS-CoV-2 Delta Variant in Florida, US.
Cella, Eleonora; Ali, Sobur; Schmedes, Sarah E; Rife Magalis, Brittany; Marini, Simone; Salemi, Marco; Blanton, Jason; Azarian, Taj.
  • Cella E; Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL 32827, USA.
  • Ali S; Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL 32827, USA.
  • Schmedes SE; Bureau of Public Health Laboratories, Florida Department of Health, Jacksonville, FL 32202, USA.
  • Rife Magalis B; Emerging Pathogens Institute, University of Florida, Gainesville, FL 32608, USA.
  • Marini S; Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL 32608, USA.
  • Salemi M; Department of Epidemiology, University of Florida, Gainesville, FL 32608, USA.
  • Blanton J; Emerging Pathogens Institute, University of Florida, Gainesville, FL 32608, USA.
  • Azarian T; Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL 32608, USA.
Viruses ; 14(4)2022 04 06.
Article in English | MEDLINE | ID: covidwho-1776364
ABSTRACT
SARS-CoV-2, the causative agent of COVID-19, emerged in late 2019. The highly contagious B.1.617.2 (Delta) variant of concern (VOC) was first identified in October 2020 in India and subsequently disseminated worldwide, later becoming the dominant lineage in the US. Understanding the local transmission dynamics of early SARS-CoV-2 introductions may inform actionable mitigation efforts during subsequent pandemic waves. Yet, despite considerable genomic analysis of SARS-CoV-2 in the US, several gaps remain. Here, we explore the early emergence of the Delta variant in Florida, US using phylogenetic analysis of representative Florida and globally sampled genomes. We find multiple independent introductions into Florida primarily from North America and Europe, with a minority originating from Asia. These introductions led to three distinct clades that demonstrated varying relative rates of transmission and possessed five distinct substitutions that were 3-21 times more prevalent in the Florida sample as compared to the global sample. Our results underscore the benefits of routine viral genomic surveillance to monitor epidemic spread and support the need for more comprehensive genomic epidemiology studies of emerging variants. In addition, we provide a model of epidemic spread of newly emerging VOCs that can inform future public health responses.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Randomized controlled trials Topics: Variants Limits: Humans Country/Region as subject: North America Language: English Year: 2022 Document Type: Article Affiliation country: V14040766

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Observational study / Randomized controlled trials Topics: Variants Limits: Humans Country/Region as subject: North America Language: English Year: 2022 Document Type: Article Affiliation country: V14040766